| Section | Page | | --- | --- | | Table of Contents - Investor Supplement - First Quarter 2025 | 2 | | Financial Highlights | 3 | | Summary of Earnings. | イ | | Earnings Per Share Summary | 5 | | Property and Casualty Insurance Segment | | | Property and Casualty Insurance - Summary Underwiting Results (GAAP) | | | Specialty - Underwriting Results (GAAP). | 7 | | Property and Transportation - Underwriting Results (GAAP). | 8 | | Specialty Casualty - Underwriting Results (GAAP) . | 9 | | Specialty Financial ...

Johnson Controls International plc JCI will release earnings results for the second quarter, before the opening bell on Wednesday, May 7. Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period. Considering buying JCI stock? Here's what analysts think: Analysts expect the Cork, Ireland-based company to report quarterly earnings at 80 cents per share, up from 78 cents per share in the year-ago period. Johnson Controls International projects to report quarterly r ...

Core Insights - Fidelity National Information Services (FIS) reported revenue of $2.53 billion for the quarter ended March 2025, reflecting a year-over-year increase of 2.6% [1] - Earnings per share (EPS) for the quarter was $1.21, up from $1.10 in the same quarter last year, indicating a positive trend in profitability [1] - The reported revenue exceeded the Zacks Consensus Estimate of $2.5 billion by 1.10%, and the EPS also surpassed the consensus estimate of $1.20 by 0.83% [1] Revenue Breakdown - Banking Solutions revenue was $1.72 billion, slightly above the average estimate of $1.71 billion, with a year-over-year increase of 2% [4] - Corporate and Other revenue was reported at $50 million, compared to the average estimate of $49.64 million, showing a significant year-over-year decline of 35.1% [4] - Capital Market Solutions revenue reached $764 million, exceeding the average estimate of $756.36 million, with a year-over-year growth of 8.2% [4] Adjusted EBITDA Analysis - Adjusted EBITDA for Banking Solutions was $688 million, below the average estimate of $720.66 million [4] - Adjusted EBITDA for Corporate and Other was -$99 million, better than the estimated -$129.07 million [4] - Adjusted EBITDA for Capital Market Solutions was $369 million, slightly above the average estimate of $360.18 million [4] Stock Performance - Fidelity National's shares have returned +14% over the past month, outperforming the Zacks S&P 500 composite's +11.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Voya Financial reported revenue of $294 million for Q1 2025, a 2.4% increase year-over-year, with EPS at $2.15 compared to $1.88 in the same quarter last year, exceeding Zacks Consensus Estimates for both revenue and EPS [1] - The company experienced a revenue surprise of +21.90% and an EPS surprise of +35.22% compared to analyst expectations [1] Financial Performance Metrics - Total Assets Under Management (AUM) and Assets Under Administration (AUA) in Wealth Solutions reached $694.18 billion, surpassing the average estimate of $667.24 billion [4] - Client Assets in Wealth Solutions - Full Service were $228.60 billion, below the average estimate of $252.60 billion [4] - Client Assets in Wealth Solutions - Recordkeeping were $401.12 billion, exceeding the average estimate of $351.32 billion [4] - Fee income revenue was $570 million, lower than the estimated $598.98 million but representing an 11.1% increase year-over-year [4] - Net investment income revenue was $560 million, exceeding the estimate of $493.49 million, marking a 5.9% year-over-year increase [4] - Premiums revenue was $737 million, below the estimated $807.52 million, reflecting a 7.9% decrease year-over-year [4] - Adjusted Operating Revenues for Investment Management - Total were $243 million, slightly below the estimate of $245.39 million, with a 3.9% year-over-year increase [4] - Adjusted Operating Revenues for Investment Management - Fee income was $236 million, close to the estimate of $237.09 million, with a 4% year-over-year increase [4] - Adjusted Operating Revenues for Investment Management - Net investment income and net gains (losses) were $6 million, exceeding the estimate of $5.53 million but showing a 33.3% year-over-year decline [4] - Adjusted Operating Revenues for Corporate - Net investment income and net gains (losses) were $6 million, surpassing the estimate of $5 million, with a 50% year-over-year increase [4] - Adjusted Operating Revenues for Corporate - Total were $6 million, exceeding the estimate of $5.38 million, also reflecting a 50% year-over-year increase [4] Stock Performance - Voya's shares returned +10.4% over the past month, compared to the S&P 500 composite's +11.5% change, with a Zacks Rank of 5 (Strong Sell), indicating potential underperformance in the near term [3]

Core Insights - American Financial Group (AFG) reported a revenue of $1.86 billion for the quarter ended March 2025, reflecting a decrease of 1.4% year-over-year and falling short of the Zacks Consensus Estimate of $1.93 billion, resulting in a surprise of -3.79% [1] - The earnings per share (EPS) for the quarter was $1.81, down from $2.76 in the same quarter last year, with an EPS surprise of -16.59% against the consensus estimate of $2.17 [1] Financial Performance Metrics - The company’s shares have returned +10.4% over the past month, compared to the Zacks S&P 500 composite's +11.5% change, indicating a performance in line with the broader market [3] - In the Property and Transportation segment, the Loss and LAE Ratio was reported at 62.1%, better than the estimated 66.8% [4] - The Underwriting Expense Ratio for Property and Transportation was 30.4%, slightly above the average estimate of 30.1% [4] - The Combined Ratio for Property and Transportation was 92.5%, outperforming the estimated 96.8% [4] - In the Specialty Casualty segment, the Loss and LAE Ratio was 67.6%, worse than the estimated 62.8% [4] - The Underwriting Expense Ratio for Specialty Casualty was 30%, above the average estimate of 27.7% [4] - The Combined Ratio for Property and Casualty - Specialty was reported at 94%, in line with the average estimate of 94.7% [4] - The Underwriting Expense Ratio for Specialty Financial was 45.9%, better than the estimated 46.9% [4] Revenue and Premiums - Net investment income was reported at $173 million, below the average estimate of $203.73 million, representing a year-over-year decline of 12.6% [4] - Net earned premium in the Property and Transportation segment was $500 million, significantly lower than the estimated $675.75 million, reflecting a -2.5% change year-over-year [4] - In the Specialty Casualty segment, net earned premium was $794 million, exceeding the average estimate of $759.90 million, with an 8.8% year-over-year increase [4] - Specialty Financial's net earned premium was reported at $286 million, above the average estimate of $270.42 million, indicating a year-over-year increase of 17.7% [4] - Other income (loss) was reported at $27 million, below the average estimate of $37.94 million, representing a year-over-year decline of 30.8% [4]

Core Insights - Supernus Pharmaceuticals reported $149.82 million in revenue for Q1 2025, a year-over-year increase of 4.3% and a surprise of +2.91% over the Zacks Consensus Estimate of $145.59 million [1] - The company achieved an EPS of $0.42, compared to $0.00 a year ago, with an EPS surprise of +10.53% against the consensus estimate of $0.38 [1] Revenue Breakdown - Trokendi XR generated $12.80 million in net product sales, exceeding the average estimate of $8.58 million, but representing a year-over-year decline of -20% [4] - Oxtellar XR reported $10.20 million in net product sales, below the average estimate of $12.29 million, with a significant year-over-year decrease of -62.1% [4] - Qelbree achieved $64.70 million in net product sales, slightly below the average estimate of $65.54 million, but showing a year-over-year increase of +43.5% [4] - Total net product sales amounted to $141.99 million, surpassing the average estimate of $140.61 million, reflecting a year-over-year growth of +2.6% [4] - Royalty revenues reached $7.84 million, exceeding the estimated $5.80 million, with a year-over-year increase of +51.2% [4] - GOCOVRI net product sales were $30.70 million, above the average estimate of $30.13 million, marking a year-over-year increase of +15.9% [4] - Other net product sales totaled $8.60 million, surpassing the average estimate of $7.38 million, with a year-over-year growth of +19.4% [4] - APOKYN reported $15 million in net product sales, below the average estimate of $16.70 million, reflecting a year-over-year decline of -10.2% [4] Stock Performance - Supernus shares returned +0.4% over the past month, while the Zacks S&P 500 composite increased by +11.5% [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance against the broader market in the near term [3]

Financial Performance - Varonis Systems reported $136.42 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 19.7% [1] - The EPS for the same period was $0.00, compared to -$0.03 a year ago, indicating a significant improvement [1] - The reported revenue exceeded the Zacks Consensus Estimate of $133.22 million by +2.41% [1] - The EPS surprise was +100.00%, as the consensus EPS estimate was -$0.05 [1] Key Metrics - Annual Recurring Revenues reached $664.30 million, surpassing the $657.21 million average estimate based on six analysts [4] - Maintenance and Services revenues were $16.38 million, which is -31.9% year-over-year and below the $20.06 million average estimate [4] - Term license subscriptions generated $31.49 million, compared to the $35.14 million estimated by three analysts [4] - SaaS revenues were $88.56 million, exceeding the three-analyst average estimate of $78.28 million [4] Stock Performance - Varonis shares have returned +15.3% over the past month, outperforming the Zacks S&P 500 composite's +11.5% change [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]

Core Insights - Revolve Group reported revenue of $296.71 million for the quarter ended March 2025, reflecting a 9.7% increase year-over-year and a surprise of +0.24% over the Zacks Consensus Estimate of $296 million [1] - The company's EPS was $0.16, up from $0.15 in the same quarter last year, with an EPS surprise of +23.08% compared to the consensus estimate of $0.13 [1] Financial Performance Metrics - Total orders placed were 2.31 million, matching the four-analyst average estimate [4] - Average order value was $295, lower than the estimated $305.48 by four analysts [4] - Active customers reached 2.7 million, slightly above the three-analyst average estimate of 2.69 million [4] - Geographic Net Sales for the Rest of the World were $57.47 million, below the estimated $59.35 million but showing an 11.7% increase year-over-year [4] - Geographic Net Sales in the United States were $239.24 million, exceeding the estimate of $236.04 million and representing a 9.2% year-over-year increase [4] - Net Sales for FWRD were $42.31 million, below the five-analyst average estimate of $45.23 million, with a year-over-year change of +3.2% [4] - Net Sales for REVOLVE were $254.40 million, surpassing the $250.39 million average estimate and showing a +10.8% change year-over-year [4] - Gross profit for FWRD was $15.50 million, slightly below the three-analyst average estimate of $15.99 million [4] - Gross profit for REVOLVE was $138.79 million, slightly above the three-analyst average estimate of $138.58 million [4] Stock Performance - Shares of Revolve Group have returned -2.8% over the past month, contrasting with the Zacks S&P 500 composite's +11.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Group 1 - Ultragenyx reported revenue of $139.29 million for the quarter ended March 2025, reflecting a 28% increase year-over-year [1] - The earnings per share (EPS) for the quarter was -$1.57, an improvement from -$2.03 in the same quarter last year [1] - The reported revenue was a slight miss of 1.90% compared to the Zacks Consensus Estimate of $141.99 million [1] Group 2 - Key metrics indicate that Ultragenyx shares have returned +20.9% over the past month, outperforming the Zacks S&P 500 composite's +11.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3] Group 3 - Product sales for Mepsevii reached $8.39 million, exceeding the average estimate of $7.63 million from seven analysts [4] - Dojolvi product sales were reported at $17.01 million, below the estimated $21.47 million, but showed a 4% increase compared to the previous year [4] - Evkeeza product sales were $11.03 million, surpassing the average estimate of $10.58 million, with a significant year-over-year increase of 236.8% [4] - Total product sales amounted to $91.51 million, exceeding the average estimate of $75.76 million based on four analysts, representing a year-over-year change of 46.4% [4]

Core Viewpoint - Air Lease Corporation (AL) reported strong first-quarter 2025 results, with earnings and revenues exceeding expectations, driven by increased rental revenues and aircraft sales, despite higher interest expenses [1][2]. Financial Performance - Quarterly earnings per share (EPS) reached $1.51, surpassing the Zacks Consensus Estimate of $1.24, marking a 15.3% year-over-year improvement [1]. - Total revenues amounted to $738.3 million, exceeding the Zacks Consensus Estimate of $710.8 million, and grew 11.3% year over year [2]. Revenue Breakdown - Revenues from the rental of flight equipment increased by 5% year over year to $645 million, attributed to fleet growth, although offset by a $12.7 million decrease in end-of-lease revenue [4]. - Revenues from aircraft sales, trading, and other sources surged by 90% year over year to $93 million, driven by heightened sales activity, including $61 million in gains from the sale of 16 aircraft [4]. Operating Expenses and Financial Position - Operating expenses rose by 13.4% year over year to $598.6 million [5]. - As of March 31, 2025, Air Lease owned 487 aircraft with a net book value of $28.6 billion, and the total fleet size was 804 [5]. - Cash and cash equivalents at the end of the first quarter were $456.62 million, down from $472.55 million in the previous quarter, while debt financing decreased to $19.8 billion from $20.2 billion [6]. Management Commentary - The CEO highlighted a strong quarter characterized by fleet expansion, significant sales gains, and insurance settlements related to aircraft in Russia, while noting no aircraft deliveries to countries with reciprocal tariffs [3]. - The company continues to benefit from robust global aircraft demand amid significant supply constraints [3].